JP2025060647A5 - - Google Patents

Info

Publication number
JP2025060647A5
JP2025060647A5 JP2024213945A JP2024213945A JP2025060647A5 JP 2025060647 A5 JP2025060647 A5 JP 2025060647A5 JP 2024213945 A JP2024213945 A JP 2024213945A JP 2024213945 A JP2024213945 A JP 2024213945A JP 2025060647 A5 JP2025060647 A5 JP 2025060647A5
Authority
JP
Japan
Prior art keywords
composition
proteins
risk
subject
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024213945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025060647A (ja
Filing date
Publication date
Priority claimed from JP2021530081A external-priority patent/JP7688576B6/ja
Application filed filed Critical
Publication of JP2025060647A publication Critical patent/JP2025060647A/ja
Publication of JP2025060647A5 publication Critical patent/JP2025060647A5/ja
Pending legal-status Critical Current

Links

JP2024213945A 2018-11-28 2024-12-06 共生ウイルスに対するt細胞指向性抗がんワクチン Pending JP2025060647A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201862772443P 2018-11-28 2018-11-28
US62/772,443 2018-11-28
US201962831691P 2019-04-09 2019-04-09
US62/831,691 2019-04-09
US201962909698P 2019-10-02 2019-10-02
US62/909,698 2019-10-02
JP2021530081A JP7688576B6 (ja) 2018-11-28 2019-11-26 共生ウイルスに対するt細胞指向性抗がんワクチン
PCT/US2019/063172 WO2020112720A1 (en) 2018-11-28 2019-11-26 T cell-directed anti-cancer vaccines against commensal viruses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021530081A Division JP7688576B6 (ja) 2018-11-28 2019-11-26 共生ウイルスに対するt細胞指向性抗がんワクチン

Publications (2)

Publication Number Publication Date
JP2025060647A JP2025060647A (ja) 2025-04-10
JP2025060647A5 true JP2025060647A5 (https=) 2025-10-06

Family

ID=70853016

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021530081A Active JP7688576B6 (ja) 2018-11-28 2019-11-26 共生ウイルスに対するt細胞指向性抗がんワクチン
JP2024213945A Pending JP2025060647A (ja) 2018-11-28 2024-12-06 共生ウイルスに対するt細胞指向性抗がんワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021530081A Active JP7688576B6 (ja) 2018-11-28 2019-11-26 共生ウイルスに対するt細胞指向性抗がんワクチン

Country Status (5)

Country Link
US (1) US20220001004A1 (https=)
EP (1) EP3886886A4 (https=)
JP (2) JP7688576B6 (https=)
CN (1) CN113347987A (https=)
WO (1) WO2020112720A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7688576B6 (ja) * 2018-11-28 2025-07-04 ザ ジェネラル ホスピタル コーポレイション 共生ウイルスに対するt細胞指向性抗がんワクチン
WO2022159652A1 (en) * 2021-01-21 2022-07-28 The General Hospital Corporation T cell-directed anti-cancer vaccines against commensal viruses for treating mucosal carcinomas
US20230178197A1 (en) * 2021-12-03 2023-06-08 nference, inc. Techniques for predicting immunosuppression status
CN117982638B (zh) * 2024-02-04 2024-11-01 上海安奕康生物科技有限公司 免疫佐剂联合pd-1抗体药物在治疗胰腺癌中的应用
WO2025212374A1 (en) * 2024-04-02 2025-10-09 The General Hospital Corporation Methods for utilizing commensal polyomavirus for cancer therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT973546E (pt) * 1997-04-08 2004-06-30 Merck & Co Inc Formulacoes estabilizadas de virus de papiloma humano
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
EP1417353A4 (en) * 2001-07-20 2005-08-03 Univ Texas METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN
AU2005222776A1 (en) * 2003-12-31 2005-09-29 Genimmune N.V. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
EP2468763B1 (en) * 2007-05-31 2014-06-18 Academisch Ziekenhuis Leiden h.o.d.n. LUMC HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
US9149517B2 (en) * 2007-11-02 2015-10-06 The Johns Hopkins University Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection
US9717783B2 (en) * 2010-02-09 2017-08-01 Stc.Unm Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods
CN102229660B (zh) * 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
AU2016274655B2 (en) * 2015-06-10 2021-06-17 NeoTrail Therapeutics, Inc. HPV vaccines
JP7688576B6 (ja) * 2018-11-28 2025-07-04 ザ ジェネラル ホスピタル コーポレイション 共生ウイルスに対するt細胞指向性抗がんワクチン

Similar Documents

Publication Publication Date Title
JP2025060647A5 (https=)
JP2022509221A5 (https=)
CN111315407B (zh) 一种广谱抗流感疫苗免疫原及其应用
KR101514473B1 (ko) 다중 유전자 발현용 벡터
JP2014534202A5 (https=)
JP6558699B2 (ja) 抗原提示を促進するエピトープ間配列を含むt細胞誘導ワクチン
TWI399213B (zh) 抗藍舌病病毒之重組疫苗
Li et al. Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2
JP2019506175A5 (https=)
EP2413964A4 (en) VACCINE COMPOSITIONS AND METHODS OF USE
Brown et al. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection
Zhang et al. Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effect of a DNA vaccine against spring viremia of carp virus in common carp
JP2022513019A5 (https=)
JP2022513021A5 (https=)
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
JP2024521098A5 (https=)
Yu et al. Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum
JP2022539157A5 (https=)
RU2015115785A (ru) Мсн-специфичные пептиды со смещенной рамкой считывания (псрс) для предотвращения и лечения рака
JP2013512866A5 (https=)
CN115089700A (zh) 一种抗β属冠状病毒的疫苗组合物及其应用
CN111655282A (zh) 一种对抗动物增生性肠病的重组疫苗
Liu et al. The route of inoculation determines the tissue tropism of modified vaccinia tiantan expressing the spike glycoprotein of SARS‐CoV in mice
JP2024503894A5 (https=)
WO2023285976A1 (en) Composition and uses thereof